Using a multidimensional integrative analysis, we identified, for the first time in GIST, molecules and pathways modulated by RKIP that may potentially drive metastasis and, consequently, poor prognosis in this disease. The gene discussed is PEBP1; the disease is gastrointestinal stromal tumor.